Safety and Tolerability of Once-Daily Controlled-Release Carvedilol 10-80mg in Japanese Patients With Chronic Heart Failure
Author:
Affiliation:
1. Departments of Clinical Research and Development, and Cardiovascular Medicine, National Cerebral and Cardiovascular Center
2. Development and Medical Affairs Division, GlaxoSmithKline K.K.
Publisher
Japanese Circulation Society
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Link
http://www.jstage.jst.go.jp/article/circj/76/3/76_CJ-11-0210/_pdf
Reference45 articles.
1. More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure
2. Chronic heart failure in Japan: Implications of the CHART studies
3. 3. Currie PJ, Kelly MJ, McKenzie A, Harper RW, Lim YL, Federman J, et al. Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy. J Am Coll Cardiol 1984; 3: 203-209.
4. 4. Epstein S, Robinson BF, Kahler RL, Braunwald E. Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man. J Clin Invest 1965; 44: 1745-1753.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effects of carvedilol on human prostate tissue contractility and stromal cell growth pointing to potential clinical implications;Pharmacological Reports;2024-06-11
2. Titration of medications and outcomes in multi‐ethnic heart failure cohorts (with reduced ejection fraction) from Singapore and New Zealand;ESC Heart Failure;2023-02
3. Extended-Release Carvedilol in the Treatment of Hypertension: A Double-Blind, Randomized, Placebo-Controlled Trial;ACTA CARDIOL SIN;2021
4. Association between body surface area and prescribed doses of guideline‐directed medications among international patients with heart failure and reduced ejection fraction;European Journal of Heart Failure;2019-12-18
5. Preventive use of carvedilol for anthracycline-induced cardiotoxicity: a systematic review and meta-analysis of randomized controlled trials;Herz;2019-01-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3